CARD8 and COVID-19: Our data showing that SARS-CoV-2 infection activates the CARD8 inflammasome in THP-1 cells is consistent with findings that inflammasome activation contributes to severe COVID-19 and suggests that the CARD8 inflammasome in monocytes and macrophages contribute to inflammation in COVID-19 patients.